Learn about conventional, complementary, and integrative therapies.
Dealing with treatment side effects? Learn about evidence-based therapies to alleviate your symptoms.
Click the orange button to the right to learn more.
We suggest that this series of events results in a stoppage of the (retinoblastoma) cell cycle progression at the G1–>S phase transition thereby leading to a G0/G1 arrest and subsequent apoptotic
Continue reading“Despite excellent survival rates among children treated for Rb, survivors with a germline mutation in their Rb1 gene (hereditary Rb) are prone to subsequent cancers including sarcomas, melanoma,
Continue readingthe predisposition to this type of retinoblastoma (ret) can be inherited, so the other eye of the child and those of infant relatives are at risk to develop tumours… Retinoblastoma. One of the key
Continue readingI believe my risk of therapy-related secondary cancer is high and increases annually. Because I haven’t had a secondary cancer in over 28 years post chemo and radiation, I think I’m doing something
Continue readingCervical Cancer Patients Must Think Outside the Box to Reach Long-Term Remission while Minimizing Collateral Damage aka Side Effects A cancer diagnosis is one of the most difficult life experiences you
Continue reading“In this report we show that hyaluronan (HA), a major nonprotein glycosaminoglycan component of the extracellular matrix in mammalian bone marrow, is a survival and proliferation factor for human
Continue readingThe leading cause of legal blindness, age-related macular degeneration affects more than 10 million Americans — more than cataracts and glaucoma combined Aggressive, high-dose chemotherapy and radiation
Continue readingIf you are undergoing treatments for cancer, you may experience abnormalities in some parts of your body. Issues with your eyes is one of the more common side effects for cancer treatments. It will help
Continue readingThe agent (CG0070) yielded an overall 12-month complete response (CR) rate of 30% in a phase 2 single-arm trial in patients with BCG-unresponsive, high-grade Ta, T1, or CIS ± Ta/T1 non-muscle-invasive
Continue reading